When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

J . H . LEVY ,* W. AGENO,† N. C . CHAN,‡ M. CROWTHER ,§ P . VERHAMME ¶ and J . I . WE ITZ ,§ FOR THE SUBCOMMITTEE ON CONTROL OF ANT ICOAGULAT ION *Duke University School of Medicine, Durham, NC, USA; †University of Insubria, Varese, Italy; ‡Monash University, Clayton, Vic., Australia; §McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada; and ¶University of Leuven, Leuven, Belgium